TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32699176

Group type: EXPERIMENTAL
Intervention: NEWSUP (new food supplement, high in plant polyphenols and omega 3 fatty acids, fortified with micronutrients, high protein content)
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: NEWSUP
Number of subjects: 1059
Study: 36078788

Group type: EXPERIMENTAL
Intervention: PEFLOW (Pelvic Floor Workout) performed online under the supervision of a physiotherapist for 12 weeks
Number of subjects: 260

Group type: COMPARATOR
Intervention: No intervention (Control Group)
Number of subjects: 260
Study: 33567780

Group type: EXPERIMENTAL
Intervention: Spirulina maxima intake (5 g/day)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Spirulina maxima intake (5 g/day) + Exercise program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no Spirulina or exercise)
Number of subjects: 52
Study: 34941611

Group type: EXPERIMENTAL
Intervention: CHO mouth rinse
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 35130898

Group type: EXPERIMENTAL
Intervention: selfBACK app (AI-based app for self-management support)
Number of subjects: 461
Study: 34097526

Group type: EXPERIMENTAL
Intervention: Workplace wellness program including modules on nutrition, physical activity, and stress reduction, implemented by registered dietitians.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no workplace wellness program).
Number of subjects: 160
Study: 33375174

Group type: EXPERIMENTAL
Intervention: Fish oil + probiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotics + placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fish oil + placebo
Number of subjects: 0
Study: 33786663

Group type: EXPERIMENTAL
Intervention: Anatomical position
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Risk position (abducted and externally rotated arm position)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nonunion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clinical outcomes (Constant, Rowe, Walch-Duplay scores)
Number of subjects: 24
Study: 32725604

Group type: EXPERIMENTAL
Intervention: Abbott iSTAT
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Nova StatSensor
Number of subjects: 186

Group type: COMPARATOR
Intervention: Laboratory method (Beckman AU5800)
Number of subjects: 186
Study: 36458667

Group type: EXPERIMENTAL
Intervention: PECS I/II plus ultrasound-guided ropivacaine (0.5%)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard general anaesthesia
Number of subjects: 80
Study: 33641534

Group type: EXPERIMENTAL
Intervention: Percutaneous posteroanterior screw fixation (group 1)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Percutaneous anteroposterior screw fixation (group 2)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study: 32710677

Group type: EXPERIMENTAL
Intervention: Salt substitute (70% sodium chloride and 30% potassium chloride)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Usual salt (100% sodium chloride)
Number of subjects: 502
Study: 35068386

Group type: EXPERIMENTAL
Intervention: 3 mg warfarin
Number of subjects: 56

Group type: COMPARATOR
Intervention: 5 mg warfarin
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: VKORC1-1639G > A
Number of subjects: 56
Study: 34383324

Group type: EXPERIMENTAL
Intervention: ProTaper Retreatment + ProTaper Gold
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Hyflex EDM
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Reciproc Blue
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: WaveOne Gold
Number of subjects: 180
Study: 32107871

Group type: EXPERIMENTAL
Intervention: Home titration using an APAP device for three days
Number of subjects: 53

Group type: COMPARATOR
Intervention: Laboratory attended APAP titration
Number of subjects: 53
Study: 35727844

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided TAP (UTAP)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Robotic TAP (RTAP)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Local Anesthetic (LA)
Number of subjects: 143

Group type: COMPARATOR
Intervention: All groups (UTAP, RTAP, LA)
Number of subjects: 143
Study: 32990891

Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mental Imagery (Control)
Number of subjects: 36
Study: 33512419

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation (allo-SCT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Autologous stem cell transplantation (auto-SCT)
Number of subjects: 104
Study: 32678435

Group type: EXPERIMENTAL
Intervention: Natural mineral waters with manufacturing time (Tm) ≥ 2 years
Number of subjects: 99

Group type: COMPARATOR
Intervention: Natural mineral waters with Tm of 0-1 year or Tm of 1-2 years
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Presence of bacteria and viruses in water samples
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Human adenovirus and norovirus
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Brands of natural mineral waters
Number of subjects: 99
Study: 34999282

Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 114
Study: 33843502

Group type: COMPARATOR
Intervention: Surfactant nasal irrigation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sodium hyaluronate nasal irrigation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 120
Study: 32334513

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 25 mL kg‐1 of Ringer's lactate over 30 min
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Induction of general anesthesia
Number of subjects: 25
Study: 35241720

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg QD
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 33246094

Group type: EXPERIMENTAL
Intervention: CryoMaze
Number of subjects: 200

Group type: COMPARATOR
Intervention: CSM
Number of subjects: 200
Study: 35533666

Group type: EXPERIMENTAL
Intervention: Real cerebellar rTMS (n = 20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham cerebellar rTMS (n = 10)
Number of subjects: 30
Study: 33781003

Group type: EXPERIMENTAL
Intervention: Foot massage with orange essential oil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Foot massage without orange essential oil (Control)
Number of subjects: 80
Study: 32741133

Group type: EXPERIMENTAL
Intervention: abobotulinumtoxinA (Dysport) injections
Number of subjects: 352
Study: 34180327

Group type: EXPERIMENTAL
Intervention: Exclusion by White women
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Exclusion by White men
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Exclusion by Black men
Number of subjects: 124
Study: 33622615

Group type: EXPERIMENTAL
Intervention: MRI STIR signal intensity at time of injury
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: MRI STIR signal intensity at RTP
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Change in MRI STIR signal intensity over time
Number of subjects: 51
Study: 34791912

Group type: EXPERIMENTAL
Intervention: Dorzolamide hydrochloride + Timolol maleate
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Brimonidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 90
Study: 33140878

Group type: EXPERIMENTAL
Intervention: MAFLD group
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Higher ALT level
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Higher uric acid
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Higher total cholesterol
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Greater waist–height ratio
Number of subjects: 361
Study: 32059101

Group type: EXPERIMENTAL
Intervention: Complex care management (n = 71)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Usual care (n = 127)
Number of subjects: 253
Study: 35417915

Group type: EXPERIMENTAL
Intervention: Behavioural weight management programme (WW) for 12‐weeks or 52‐weeks
Number of subjects: 1267
Study: 32939858

Group type: EXPERIMENTAL
Intervention: Visual gait biofeedback (GBF)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No biofeedback (NBF)
Number of subjects: 27
Study: 32370596

Group type: EXPERIMENTAL
Intervention: Antibody 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibody 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibody 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All three antibodies
Number of subjects: 0
Study: 35508008

Group type: EXPERIMENTAL
Intervention: Inhaled ciclesonide + placebo
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hydrocortisone + placebo
Number of subjects: 58
Study: 33315809

Group type: EXPERIMENTAL
Intervention: Endurance Training (END) 5 d·wk-1, 30-40 min, 60% Wpeak, n=11
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sprint Interval Training (SIT) 3 d·wk-1, 4-6 × 30 s170% Wpeak, 2 min recovery, n=12
Number of subjects: 23
Study: 34230983

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) + standard physiotherapy (PT)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard rehabilitation (SR)
Number of subjects: 106
Study: 33108574

Group type: EXPERIMENTAL
Intervention: Anodal ctDCS (2 mA for 20 min)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cathodal ctDCS (2 mA for 20 min)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham ctDCS
Number of subjects: 36
Study: 35843914

Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg during induction and 2 mg/kg/h after intubation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg during induction)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (1.5 gr/hr as continuous intravenous infusion after intubation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control time points (1, 4, 8, 12, and 24 hours after surgery)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fentanyl (bolus doses during surgery)
Number of subjects: 120
Study: 34525418

Group type: EXPERIMENTAL
Intervention: QSTR model using Genetic Algorithm Multi‐linear regression (GA‐MLR)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: QSTR model
Number of subjects: 271
Study: 35613149

Group type: EXPERIMENTAL
Intervention: Target-D intervention
Number of subjects: 1868
Study: 33407599

Group type: EXPERIMENTAL
Intervention: Whole tomato food supplement (WTFS) 5g daily for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Whole tomato food supplement (WTFS)
Number of subjects: 40
Study: 35713160

Group type: EXPERIMENTAL
Intervention: Standard treatment plus 20 g vitamin C once daily (1-10 days) and 500 mg twice daily (11-100 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 24
Study: 32885637

Group type: EXPERIMENTAL
Intervention: Frinozol (nasal spray phenylephrinein 0.25% + cetirizine 0.25%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rinostop Extra (nasal spray oxymetazoline 0.05%)
Number of subjects: 60
Study: 35690931

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance and Impact Training (HiRIT)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Combination of HiRIT and medication
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-Intensity, Pilates-based Exercise (LiPBE)
Number of subjects: 102
Study: 33727512

Group type: EXPERIMENTAL
Intervention: Longitudinal faculty development program (FDP), implemented once-per-week over 3 years.
Number of subjects: 480
Study: 32209619

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Standard moist wound care (SMWC)
Number of subjects: 368
Study: 33906822

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine 0.25% (50 μL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Epidural saline (50 μL, control)
Number of subjects: 10
Study: 32430454

Group type: EXPERIMENTAL
Intervention: Editorial intervention using an R Shiny application to evaluate completeness of reporting of eight core CONSORT items
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual peer review process (Control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Editorial intervention
Number of subjects: 24
Study: 34201617

Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whey Protein/Casein (WP/CAS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Casein/Whey Protein (CAS/WP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Casein (CAS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study: 32162831

Group type: EXPERIMENTAL
Intervention: Machine learning models for predicting epoxidation
Number of subjects: 884
Study: 35922010

Group type: EXPERIMENTAL
Intervention: Open Reduction and Internal Fixation (ORIF)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Closed Reduction (CR)
Number of subjects: 116
Study: 34609451

Group type: EXPERIMENTAL
Intervention: Usual care plus an active strategy for diagnosing PE (D-dimer testing and, if positive, computed tomography pulmonary angiogram) (n=370)
Number of subjects: 746

Group type: COMPARATOR
Intervention: Usual care (n=367)
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Usual care plus an active strategy for diagnosing PE
Number of subjects: 746

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 746
Study: 32085539

Group type: EXPERIMENTAL
Intervention: Monthly budget
Number of subjects: 2691

Group type: EXPERIMENTAL
Intervention: Place of permanent residence
Number of subjects: 2691

Group type: EXPERIMENTAL
Intervention: Parents' educational attainment
Number of subjects: 2691
Study: 35279138

Group type: EXPERIMENTAL
Intervention: Participation in the ARena project
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Work experience
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: PCN environment
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Structural conditions
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Environment of existing processes
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Externally defined general conditions
Number of subjects: 126
Study: 33773362

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) 4‐hour infusions at 0.5 μg/kg/min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 35470189

Group type: EXPERIMENTAL
Intervention: Partial preservation of Denonvilliers' fascia (PP-DVF)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Complete preservation of Denonvilliers' fascia (CP-DVF)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: PP-DVF
Number of subjects: 278

Group type: COMPARATOR
Intervention: CP-DVF
Number of subjects: 278
Study: 33541314

Group type: EXPERIMENTAL
Intervention: Gym-based exercise intervention monitored via telehealth
Number of subjects: 15
Study: 36218952

Group type: EXPERIMENTAL
Intervention: Email alerts to practitioners
Number of subjects: 2237

Group type: COMPARATOR
Intervention: As-usual care
Number of subjects: 2237
Study: 33550719

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (nutritional counseling, specific menu with recommended energy, protein, and formula milk for 2 months)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 32345685

Group type: EXPERIMENTAL
Intervention: Families Talking Together (FTT) intervention
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 900
Study: 35854423

Group type: EXPERIMENTAL
Intervention: Praise text messages
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study: 34326136

Group type: EXPERIMENTAL
Intervention: Comprehensive secondary prevention programme
Number of subjects: 537

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 537
Study: 36465647

Group type: EXPERIMENTAL
Intervention: T2DM plus aerobic exercise (T2DM+AE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: T2DM plus high-intensity interval training (T2DM+HIIT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: T2DM plus swimming (T2DM+S)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: T2DM plus resistance exercise (T2DM+RE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: T2DM group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 48
Study: 34501535

Group type: EXPERIMENTAL
Intervention: Online Gottman's Psychoeducational Intervention (O‐GPI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (parenting skills information via email)
Number of subjects: 72
Study: 35247794

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Oral antipsychotics (OAP)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP/PP)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Oral antipsychotics (OAP/PP)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Oral antipsychotics (OAP/OAP)
Number of subjects: 235
Study: 35962133

Group type: EXPERIMENTAL
Intervention: E‐cig vapor (e‐liquid pH 9.4)
Number of subjects: 16

Group type: COMPARATOR
Intervention: C‐cig smoke
Number of subjects: 16
Study: 32594511

Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Bi-level CPAP
Number of subjects: 151

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 151
Study: 34431835

Group type: EXPERIMENTAL
Intervention: Impact severity of 11g
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Impact severity of 8g
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Impact severity of 4g
Number of subjects: 72

Group type: COMPARATOR
Intervention: Posture conditions (neutral, flexed, extended)
Number of subjects: 72
Study: 34091050

Group type: EXPERIMENTAL
Intervention: Low-Dose Computed Tomography (LDCT) screening
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Non-LDCT screen-detected PLC
Number of subjects: 1502

Group type: EXPERIMENTAL
Intervention: LDCT screening in early stage PLC
Number of subjects: 1502

Group type: EXPERIMENTAL
Intervention: LDCT screening in patients who underwent surgery
Number of subjects: 1502
Study: 32448257

Group type: EXPERIMENTAL
Intervention: 600mcg oral misoprostol given to all women after delivery (primary prevention)
Number of subjects: 2654

Group type: COMPARATOR
Intervention: 800mcg sublingual misoprostol given only to women with 350-500 ml postpartum blood loss (secondary prevention)
Number of subjects: 2654
Study: 33411992

Group type: EXPERIMENTAL
Intervention: Autoinjector (fremanezumab 225 mg)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Prefilled syringe (fremanezumab 225 mg)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Autoinjector
Number of subjects: 216

Group type: COMPARATOR
Intervention: Prefilled syringe
Number of subjects: 216
Study: 35093625

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0
Study: 32062446

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (BoNT‐A)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 36326117

Group type: EXPERIMENTAL
Intervention: Continuation of RAS inhibitors
Number of subjects: 411

Group type: COMPARATOR
Intervention: Discontinuation of RAS inhibitors
Number of subjects: 411
Study: 32217469

Group type: EXPERIMENTAL
Intervention: Executive function (EF) features
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Subgroup identification via functional random forest (FRF)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Neuroimaging data
Number of subjects: 130
Study: 35468091

Group type: EXPERIMENTAL
Intervention: eHealth intervention (remote monitoring with blood pressure monitor, weight scale, electrocardiogram device, step counter; two in-office visits replaced by e-visits)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular follow-up (control group)
Number of subjects: 0
Study: 33872601

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone injected into masseter muscle
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone injected into gluteal muscle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 60
Study: 35017010

Group type: EXPERIMENTAL
Intervention: Intravenous GLP-1 infusion (2.5 pmol/kg/min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 21
Study: 34507060

Group type: EXPERIMENTAL
Intervention: SHAHRP intervention
Number of subjects: 13914

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13914
Study: 35776183

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 400
Study: 33934468

Group type: COMPARATOR
Intervention: Electrophysical treatment via direct leaf contact
Number of subjects: 2

Group type: COMPARATOR
Intervention: Electrophysical treatment via stem contact
Number of subjects: 2

Group type: COMPARATOR
Intervention: Electrophysical treatment at early growth stages (0.0125 W h)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Electrophysical treatment at later growth stages (0.0125 W h)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Electrophysical treatment at two-leaf growth stage (0.0025 W h)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Electrophysical treatment
Number of subjects: 2
Study: 32734848

Group type: EXPERIMENTAL
Intervention: VCV-M infection confirmed by RT-PCR and western blot (WB) detection
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mixed viral infections detected through RT-PCR and ELISA
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Northern blot assay for confirmation of VCV-M infection
Number of subjects: 17